Main public logs

Combined display of all available logs of Azupedia. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 22:13, 5 February 2024 Fire talk contribs created page 2-iminoacetate synthase activity (Q20499) (wbeditentity-create:2|en: 2-iminoacetate synthase activity, Catalysis of the reaction: L-tyrosine + S-adenosyl-L-methionine + reduced acceptor = 2-iminoacetate + 4-methylphenol + 5'-deoxyadenosine + L-methionine + acceptor + 2 H+.)
• 22:12, 5 February 2024 Fire talk contribs created page 5'-deoxyadenosine (Q20498) (wbeditentity-create:2|en: 5'-deoxyadenosine, chemical compound)
• 22:11, 5 February 2024 Fire talk contribs created page biotin synthase activity (Q20497) (wbeditentity-create:2|en: biotin synthase activity, Catalysis of the reaction: 2 S-adenosyl-L-methionine + dethiobiotin + S(2-) = 2 5'-deoxyadenosine + 2 L-methionine + biotin + H(+).)
• 22:08, 5 February 2024 Fire talk contribs created page Translations:GLP-1 receptor agonist/3/ja (Created page with "GLP-1作動薬は当初2型糖尿病のために開発された。 2022年の米国糖尿病学会の医療標準では、GLP-1作動薬は2型糖尿病の第一選択薬として、特に動脈硬化性心血管病または肥満を有する患者に推奨されている。 また、GLP-1作動薬は食事摂取量と体重を有意に減少させる...")
• 22:06, 5 February 2024 Fire talk contribs created page Translations:GLP-1 receptor agonist/2/ja (Created page with "'''グルカゴン様ペプチド-1（GLP-1）受容体作動薬'''は、'''GLP-1アナログ'''、'''GLP-1DA'''または'''インクレチン模倣薬'''としても知られており、GLP-1受容体を活性化することによって血糖値とエネルギー摂取量を減少させる薬物の一種である。食後に腸から分泌される内因性のインクレチンホルモンGLP...")
• 22:03, 5 February 2024 Fire talk contribs created page water-soluble vitamin catabolic process (Q20496) (wbeditentity-create:2|en: water-soluble vitamin catabolic process, The chemical reactions and pathways resulting in the breakdown of any of a diverse group of vitamins that are soluble in water.)
• 22:03, 5 February 2024 Fire talk contribs created page biotin catabolic process (Q20495) (wbeditentity-create:2|en: biotin catabolic process, The chemical reactions and pathways resulting in the breakdown of biotin, cis-tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid.)
• 22:01, 5 February 2024 Fire talk contribs created page GLP-1 receptor agonist/ja (Created page with "GLP-1受容体作動薬")
• 22:01, 5 February 2024 Fire talk contribs created page Translations:GLP-1 receptor agonist/1/ja (Created page with "{{Drug List/ja|state6=uncollapsed}} {{Pathnav|Medication/ja|Diabetes medication/ja|frame=1}}")
• 22:00, 5 February 2024 Fire talk contribs created page Translations:GLP-1 receptor agonist/Page display title/ja (Created page with "GLP-1受容体作動薬")
• 22:00, 5 February 2024 FuzzyBot talk contribs created page GLP-1 receptor agonist/en (Updating to match new version of source page)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/25/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/24/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/23/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/22/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/21/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/20/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/19/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/18/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/17/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/16/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/15/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/14/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/13/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/12/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/11/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/10/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/9/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/8/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/7/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/6/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/5/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/4/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/3/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/2/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/1/en (Importing a new version from external source)
• 21:59, 5 February 2024 FuzzyBot talk contribs created page Translations:GLP-1 receptor agonist/Page display title/en (Importing a new version from external source)
• 21:59, 5 February 2024 Fire talk contribs marked GLP-1 receptor agonist for translation
• 21:59, 5 February 2024 Fire talk contribs limited languages for translatable page GLP-1 receptor agonist to Japanese
• 21:55, 5 February 2024 Fire talk contribs created page Category:GLP-1 receptor agonists (Created page with "Category:Anti-diabetic_drugs Category:Hormonal agents Category:Anti-obesity drugs")
• 21:52, 5 February 2024 Fire talk contribs deleted page Item:Q20482 (content was: "diabetes medication", and the only contributor was "Fire" (talk))
• 21:50, 5 February 2024 Fire talk contribs created page diabetes management (Q20494) (wbeditentity-create:2|en: diabetes management, management of diabetes via effective control of blood glucose, blood pressure and lipids, to minimize the risk of long-term consequences associated with diabetes)
• 21:50, 5 February 2024 Fire talk contribs created page anti-diabetic medication (Q20493) (wbeditentity-create:2|en: anti-diabetic medication, substances which lower blood glucose levels)
• 16:53, 5 February 2024 Fire talk contribs created page glucagon-like peptide-1 agonist (Q20492) (wbeditentity-create:2|en: glucagon-like peptide-1 agonist, agonist of the GLP-1 receptor used in the treatment of type 2 diabetes)
• 16:52, 5 February 2024 Fire talk contribs created page GLP-1 receptor agonist (Created page with "{{Drug List/ja|state6=uncollapsed}} {{Short description|Agonist of the GLP-1 receptor used in the treatment of type 2 diabetes}} '''Glucagon-like peptide-1 (GLP-1) receptor agonists''', also known as '''GLP-1 analogs''', '''GLP-1DAs''' or '''incretin mimetics''', are a class of drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. They mimic the actions of the endogenous incretin hormone GLP-1...")
• 16:40, 5 February 2024 Fire talk contribs created page Glucagon-like peptide-1 receptor agonist (Created page with "#REDIRECDT GLP-1 receptor agonist")
• 16:40, 5 February 2024 Fire talk contribs created page Glucagon-like peptide-1 receptor agonist/ja (Redirected page to GLP-1受容体作動薬) Tag: New redirect
• 16:39, 5 February 2024 Fire talk contribs created page Anti-diabetic medication/ja (Redirected page to 糖尿病治療薬) Tag: New redirect
• 16:35, 5 February 2024 Fire talk contribs created page biotin transport (Q20491) (wbeditentity-create:2|en: biotin transport, The directed movement of biotin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Biotin is cis-tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid; the (+) enantiomer is very widely distribute)
• 15:58, 5 February 2024 Fire talk contribs created page Template:Oral hypoglycemics and insulin analogs/ja (Created page with "{{Navbox with collapsible groups | name = Oral hypoglycemics and insulin analogs/ja | title = 経口糖尿病治療薬、インスリン製剤およびインスリンアナログ製剤、糖尿病に用いられるその他の薬剤（A10） | state = {{{state<includeonly>|expanded</includeonly>}}} | listclass = hlist | group1 = インスリン/insulin analog/ja|イ...")